LAMB1
Basic information
Region (hg38): 7:107923799-108003213
Previous symbols: [ "CLM" ]
Links
Phenotypes
GenCC
Source:
- cobblestone lissencephaly without muscular or ocular involvement (Strong), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Strong), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Moderate), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Strong), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Supportive), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Strong), mode of inheritance: AR
- cobblestone lissencephaly without muscular or ocular involvement (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lissencephaly 5 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 23472759; 25925986 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (12 variants)
- Cobblestone lissencephaly without muscular or ocular involvement (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LAMB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 144 | 17 | 163 | |||
missense | 341 | 12 | 10 | 363 | ||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 17 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 8 | 29 | 4 | 41 | ||
non coding | 116 | 86 | 206 | |||
Total | 14 | 11 | 360 | 272 | 113 |
Highest pathogenic variant AF is 0.00000657
Variants in LAMB1
This is a list of pathogenic ClinVar variants found in the LAMB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-107923866-T-C | Likely benign (Jun 26, 2018) | |||
7-107923921-T-G | Benign (Jun 19, 2018) | |||
7-107923964-C-T | Uncertain significance (Aug 03, 2022) | |||
7-107923965-T-C | Cobblestone lissencephaly without muscular or ocular involvement | Uncertain significance (Dec 01, 2022) | ||
7-107923971-C-T | Uncertain significance (Jul 22, 2023) | |||
7-107923976-A-G | Uncertain significance (Jul 31, 2023) | |||
7-107923987-T-A | not specified | Likely benign (May 24, 2017) | ||
7-107923996-T-A | Likely benign (Apr 09, 2023) | |||
7-107923998-G-A | Likely benign (May 24, 2022) | |||
7-107924003-G-A | Uncertain significance (Jan 18, 2024) | |||
7-107924007-G-A | Inborn genetic diseases | Uncertain significance (Jul 14, 2023) | ||
7-107924030-A-C | Uncertain significance (Nov 01, 2022) | |||
7-107924035-T-A | Inborn genetic diseases | Uncertain significance (Oct 05, 2023) | ||
7-107924040-C-A | Uncertain significance (Aug 09, 2021) | |||
7-107924040-C-T | Uncertain significance (Mar 01, 2017) | |||
7-107924044-A-G | not specified | Likely benign (Sep 19, 2016) | ||
7-107924055-A-ATCTT | Uncertain significance (Jul 28, 2023) | |||
7-107924062-A-G | LAMB1-related disorder | Likely benign (Apr 29, 2022) | ||
7-107924065-G-A | not specified | Benign (Dec 30, 2023) | ||
7-107924066-TC-T | Uncertain significance (Dec 30, 2023) | |||
7-107924085-A-T | Uncertain significance (Mar 22, 2022) | |||
7-107924091-TGG-T | not specified | Benign (Jan 19, 2024) | ||
7-107924093-GGGAGAT-G | Likely benign (Nov 24, 2023) | |||
7-107924094-G-A | Maple syrup urine disease • Pyruvate dehydrogenase complex deficiency • Leigh syndrome • not specified • Cobblestone lissencephaly without muscular or ocular involvement | Benign (Feb 01, 2024) | ||
7-107924095-G-T | Conflicting classifications of pathogenicity (Nov 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LAMB1 | protein_coding | protein_coding | ENST00000222399 | 33 | 79457 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.07e-22 | 1.00 | 125606 | 0 | 142 | 125748 | 0.000565 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.544 | 965 | 1.01e+3 | 0.952 | 0.0000569 | 11805 |
Missense in Polyphen | 327 | 394.45 | 0.82901 | 4417 | ||
Synonymous | 0.185 | 375 | 380 | 0.988 | 0.0000230 | 3260 |
Loss of Function | 4.64 | 53 | 104 | 0.509 | 0.00000617 | 1163 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000880 | 0.000880 |
Ashkenazi Jewish | 0.000697 | 0.000695 |
East Asian | 0.000383 | 0.000381 |
Finnish | 0.000280 | 0.000277 |
European (Non-Finnish) | 0.000697 | 0.000695 |
Middle Eastern | 0.000383 | 0.000381 |
South Asian | 0.000426 | 0.000425 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Involved in the organization of the laminar architecture of cerebral cortex. It is probably required for the integrity of the basement membrane/glia limitans that serves as an anchor point for the endfeet of radial glial cells and as a physical barrier to migrating neurons. Radial glial cells play a central role in cerebral cortical development, where they act both as the proliferative unit of the cerebral cortex and a scaffold for neurons migrating toward the pial surface. {ECO:0000269|PubMed:23472759}.;
- Disease
- DISEASE: Lissencephaly 5 (LIS5) [MIM:615191]: An autosomal recessive brain malformation characterized by cobblestone changes in the cortex, more severe in the posterior region, and subcortical band heterotopia. Affected individuals have hydrocephalus, seizures, and severely delayed psychomotor development. {ECO:0000269|PubMed:23472759}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Small cell lung cancer - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Alpha 6 Beta 4 signaling pathway;Human Complement System;Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Inflammatory Response Pathway;Developmental Biology;Signal Transduction;prion pathway;Post-translational protein phosphorylation;Alpha6Beta4Integrin;Laminin interactions;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Beta3 integrin cell surface interactions;agrin in postsynaptic differentiation;Degradation of the extracellular matrix;a6b1 and a6b4 Integrin signaling;L1CAM interactions;Non-integrin membrane-ECM interactions;Axon guidance;ECM proteoglycans;MET activates PTK2 signaling;MET promotes cell motility;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Beta1 integrin cell surface interactions;Alpha6 beta4 integrin-ligand interactions
(Consensus)
Recessive Scores
- pRec
- 0.501
Intolerance Scores
- loftool
- 0.631
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.55
Haploinsufficiency Scores
- pHI
- 0.839
- hipred
- Y
- hipred_score
- 0.589
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.915
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lamb1
- Phenotype
- muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- lamb1a
- Affected structure
- fast muscle myoblast
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- cell adhesion;neuronal-glial interaction involved in cerebral cortex radial glia guided migration;extracellular matrix organization;positive regulation of cell migration;neuron projection development;substrate adhesion-dependent cell spreading;endodermal cell differentiation;odontogenesis;post-translational protein modification;cellular protein metabolic process;positive regulation of epithelial cell proliferation
- Cellular component
- extracellular region;basement membrane;laminin-1 complex;laminin-2 complex;extracellular space;endoplasmic reticulum lumen;laminin-8 complex;laminin-10 complex;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- structural molecule activity;extracellular matrix structural constituent;protein binding